{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:53:13Z","timestamp":1778561593173,"version":"3.51.4"},"reference-count":22,"publisher":"Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v102.2076","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T09:32:55Z","timestamp":1646127175000},"page":"adv00711","source":"Crossref","is-referenced-by-count":4,"title":["Chilblain-like Lesions after COVID-19 Vaccination: A Case Series"],"prefix":"10.2340","volume":"102","author":[{"given":"Roberto","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Cozzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Micalizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"18608","doi-asserted-by":"crossref","unstructured":"Kanitakis J, Lesort C, Danset M, Jullien D. Chilblain-like acral lesions during the COVID-19 pandemic (\"COVID toes\"): histologic, immunofluorescence, and immunohistochemical study of 17 cases. J Am Acad Dermatol 2020; 83: 870-875.","DOI":"10.1016\/j.jaad.2020.05.145"},{"key":"18609","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2020.05.145","DOI":"10.1016\/j.jaad.2020.05.145"},{"key":"18610","doi-asserted-by":"crossref","unstructured":"Battesti G, Descamps V. Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains. Br J Dermatol 2020; 183: 1151.","DOI":"10.1111\/bjd.19483"},{"key":"18611","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.19483","DOI":"10.1111\/bjd.19483"},{"key":"18612","doi-asserted-by":"crossref","unstructured":"Hubiche T, Cardot-Leccia N, Le Duff F, Seitz-Polski B, Giordana P, Chiaverini C, et al. Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic. JAMA Dermatol 2021; 157: 202-206.","DOI":"10.1001\/jamadermatol.2020.4324"},{"key":"18613","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.4324","DOI":"10.1001\/jamadermatol.2020.4324"},{"key":"18614","doi-asserted-by":"crossref","unstructured":"Colmenero I, Santonja C, Alonso-Ria\u00f1o M, Noguera-Morel L, Hern\u00e1ndez-Mart\u00edn A, Andina D, et al. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol 2020; 183: 729-737.","DOI":"10.1111\/bjd.19327"},{"key":"18615","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.19327","DOI":"10.1111\/bjd.19327"},{"key":"18616","doi-asserted-by":"crossref","unstructured":"Lesort C, Kanitakis J, Donzier L, Jullien D. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2. J Eur Acad Dermatol Venereol 2021; 35: e630-e632.","DOI":"10.1111\/jdv.17451"},{"key":"18617","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17451","DOI":"10.1111\/jdv.17451"},{"key":"18618","doi-asserted-by":"crossref","unstructured":"Davido B, Mascitti H, Fortier-Beaulieu M, Jaffal K, de Truchis P. 'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine. J Travel Med 2021; 28: taab024.","DOI":"10.1093\/jtm\/taab024"},{"key":"18619","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/jtm\/taab024","DOI":"10.1093\/jtm\/taab024"},{"key":"18620","doi-asserted-by":"crossref","unstructured":"Meara AS, Silkowski M, Quin K, Jarjour W. A case of chilblains-like lesions post SARS-CoV-2 vaccine? J Rheumatol 2021; 48: 1754.","DOI":"10.3899\/jrheum.210226"},{"key":"18621","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3899\/jrheum.210226","DOI":"10.3899\/jrheum.210226"},{"key":"18622","doi-asserted-by":"crossref","unstructured":"Holmes GA, Desai M, Limone B, Love, J, Tawfik M, Wong L, Furukawa B. A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Rep 2021; 16: 53-57.","DOI":"10.1016\/j.jdcr.2021.07.038"},{"key":"18623","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.07.038","DOI":"10.1016\/j.jdcr.2021.07.038"},{"key":"18624","doi-asserted-by":"crossref","unstructured":"Pileri A, Guglielmo A, Raone B, Patrizi A. Chilblain lesions after COVID-19 mRNA vaccine. Br J Dermatol 2021; 185: e3.","DOI":"10.1111\/bjd.20060"},{"key":"18625","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.20060","DOI":"10.1111\/bjd.20060"},{"key":"18626","doi-asserted-by":"crossref","unstructured":"McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol 2021; 85: 46-55.","DOI":"10.1016\/j.jaad.2021.03.092"},{"key":"18627","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2021.03.092","DOI":"10.1016\/j.jaad.2021.03.092"},{"key":"18628","doi-asserted-by":"crossref","unstructured":"Cameli N, Silvestri M, Mariano M, Nistic\u00f2 SP, Cristaudo A. Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021; 35: e725-e727.","DOI":"10.1111\/jdv.17500"},{"key":"18629","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17500","DOI":"10.1111\/jdv.17500"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2076\/4153","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2076\/4154","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2076\/4153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T17:18:27Z","timestamp":1655918307000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/2076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":22,"URL":"https:\/\/doi.org\/10.2340\/actadv.v102.2076","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,10]]}}}